文献库搜索 | GeneLibs

Korphaisarn(K),Wirasorn(K),Tanasanvimon(S)... Oncol Res None

...Most patients had Child-Pugh A (92%), while 24% had macrovascular invasion, including five with Vp4 portal vein involvem...

Chowdhury(A),Mizikovsky(J) Toxicol Rep 2026-12-00

...mosalate (410) and zinc oxide (243). A targeted review of nine recurring organic filters identified three structural pro...

Hortúa-López(L),Cerezo(MP),Roa(VP),Rodrígu... Vet World 2026-07-31

...MOS), fructooligosaccharides (FOS), and potato resistant starch (RS) on productive performance, intestinal integrity, an...

Sarkar(B) Br J Radiol 2026-08-24

...mOS 19.5months; carbon-ion therapy reported 95% 1-year LC. Distant progression (60%) predominated. SBRT provides high lo...

Chudievich(S),Pospelova(M),Ulitin(A),Ruzan... J Clin Med 2026-07-29

...mOS) ranges from 11-16 months, and median progression-free survival (mPFS) from 4-9.5 months. In recurrent glioblastoma,...

Yu(S),Li(J),Yu(H),Wang(Z),Xiao(Y),Wang(J),... Sensors (Basel) 2026-07-27

...MOS) array to improve gas-flow uniformity and response repeatability. A total of 960 pesticide-treated electronic-nose r...

Kalita(O),Kazda(T),Tomoszkova(S),Jancalek(... Front Oncol None

...mOS 29.3 vs 12.0 months; p = 0.037), higher Karnofsky score, more radical surgical resection, and completion of the Stup...

Yan(R),Yisilamu(P),Ge(Y),Zhou(W) Thorac Cancer 2026-08-00

...mOS (HR 2.05, 95% CI 1.02-4.13, p = 0.044). Patients with ES-SCLC and comorbid diabetes exhibited significantly shorter ...

Zhang(L),Ren(Y),Zhang(Z),Zhang(B),Xu(C) Malawi Med J 2026-06-00

...MOS-HIV) scores were compared between groups. Compared with HAART alone, HAART plus Chinese herbal decoction produced mo...

Ramos-Guivar(JA),Mejía-Barraza(MA),Canchan... Discov Nano 2026-08-14

...MoS₂ (MoS₂-C) and hydrothermally synthesized MoS₂ nanosheet assemblies (MoS₂-S) were comparatively evaluated for methyl ...